INTRODUCTION
Adenosine is a neuromodulator that influences a variety of neuronal activities, including neurotransmitter release and nerve conduction [1] . Some of the important actions that are mediated by adenosine are protection of mature animals against ischaemic and excitoxic brain injury, termination of seizure activity and modulation of pain [2] .
To date, four AR (adenosine receptor) subtypes have been identified [3] . These receptor subtypes include A 1 and A 3 ARs that couple with G i and G o , and A 2A and A 2B receptors that couple with G s [4, 5] . Each of these receptors belongs to the superfamily of cellsurface receptors containing seven transmembrane-spanning domains [6] .
Of the different AR subtypes, A 1 ARs have the highest affinity for adenosine [7] . A 1 ARs are functionally coupled with pertussis toxin-sensitive G proteins and inhibit the activity of adenylate cyclase [8, 9] . A 1 AR activation can also trigger the release of [Ca 2+ ] i (intracellular calcium) [10, 11] . In the brain, A 1 ARs are expressed widely and heavily [12] . Whereas A 1 ARs are expressed on neuronal cell bodies, a notable feature of A 1 ARs is their very high expression in white-matter tissue [13] , the biological basis of which is not known.
Currently, we know little about the proteins that may physically interact with A 1 ARs to influence cellular function. We also know little about the cytoskeletal proteins that play a role in anchoring A 1 ARs to cell-surface membranes. However, based on what is known about other membrane proteins and cell-surface receptors, it is probable that A 1 ARs will interact with cytoskeletal proteins [14, 15] .
To address this issue, we used the Y2H (yeast two-hybrid) system to identify binding partners of A 1 AR. We now report that A 1 ARs bind to the erythrocyte membrane cytoskeletal protein 4.1G, which can inhibit A 1 AR action. amino acids 773-826 and 773-945 respectively. 4.1G CTD and various truncation constructs were subcloned into the pPC86 vector.
All constructs were verified by sequencing at Keck Biotechnology Resource Laboratory (Yale University, New Haven, CT, U.S.A.). Sequence analysis was performed using Lasergene (DNASTAR, Madison, WI, U.S.A.), GCG (GCG) and BLAST (National Library of Medicine) softwares.
Y2H library screening
The plasmid pDB/LP containing the third intracellular loop of the rat A 1 AR (amino acid 212-248; GenBank ® accession no. AF042079) was used as the 'bait' to screen a rat embryo cDNA library (Life Technologies, Gaithersburg, MD, U.S.A.) according to the manufacturer's recommendations. Briefly, bait plasmids were introduced into the yeast MAV203 strain containing three reporter genes, HIS + , URA + and Lac Z (Life Technologies). Transformants were then selected on defined medium lacking leucine. The rat cDNA library in pPC86 was then transformed into the resultant Leu + yeast strain and plated on a medium lacking tryptophan, leucine, histidine and uracil, but containing 25 mM 3-amino-1,2,4-trizone (SD leu − /trp − /his − /ura − / 3AT + ). After incubation for 7-10 days at 30
• C, colonies were screened for β-galactosidase activity. Individual pPC86 recombinant plasmids were verified further for interaction with the bait by repeating the Y2H assay.
Assay of protein-protein interactions by Y2H system
The Y2H system was used to investigate interactions between protein 4.1G CTD and A 1 ARs according to the manufacturer's instructions. Combinations of these constructs (one in pPC86 and the other in pDBleu) were co-transformed into MAV203 yeast cells and selected on leu − /trp − plates for double transformants. Cells were plated further on quadruple minus plates (SD leu − / trp − /his − /ura − /3AT + ) with 25 mM 3-amino-1,2,4-trizone to test for interactions [16] . Interactions were confirmed by liquid assay for β-galactosidase activity as described by the manufacturer's instructions. The vectors pDBLeu, or pPC86, without cDNA insert were used in control experiments.
Cell culture and transfection
HEK-293 cells were cultured in minimal essential medium (Life Technologies) containing 10 % (v/v) foetal bovine serum (Life Technologies). A 1 AR-CHO (CHO cells stably expressing A 1 ARs) were selected in the essential medium (F-12 HAM; Life Technologies) containing 10 % foetal bovine serum plus 1 mg/ml G418 (Geneticin; Gibco BRL, CT, U.S.A.). Cell transfections were performed with LIPOFECTAMINE TM 2000 Reagent (Life Technologies). After 36-48 h, cells were harvested and experiments were performed.
Brain tissue preparation and cell-protein extraction
The cerebral cortex from 4-to 6-week-old male Sprague-Dawley rats was homogenized in 5 vol. of RIPA buffer (50 mM Tris/HCl, pH 7.4/1 % Nonidet P40/0.25 % sodium deoxycholate/150 mM NaCl/1 mM EDTA/1 mM PMSF/1 µg/ml of each aprotinin, leupeptin and pepstatin/1 mM Na 3 VO 4 /1 mM NaF) containing protease inhibitor cocktail tablets (Roche, Indianapolis, IN, U.S.A.) using an electronic homogenizer (75 % of maximum speed, 20 s). The homogenate was then centrifuged at 2000 g for 10 min. The supernatant was then centrifuged again at 12 000 g for 15 min. The supernatant from the second centrifugation was either immediately used for immunoprecipitation or stored at − 80
• C. Cells co-transfected with A 1 AR and 4.1G were harvested and then solubilized in RIPA buffer containing protease inhibitor cocktail tablets for 30 min on ice. Cell lysates were then centrifuged at 12 000 g for 15 min at 4
• C, and the supernatant was either immediately used for immunoprecipitation studies or stored at − 80
• C.
Co-immunoprecipitation
Cells 
Confocal microscopy
A 1 AR-CHO cells were plated on poly(D-lysine)-coated coverslips (22 mm × 40 mm) and grown for 2 days in vitro. These cells were then co-transfected with pDsRed-N1 vector as a reporter (ClonTech, Palo Alto, CA, U.S.A.) or 4.1G plus pDsRed-N1 (1:5). pDsRed-N1 vector expressing red fluorescence protein has proved to be a reliable, sensitive marker for the investigation of gene expression in vivo [17] . To ensure that cells observed were successfully transfected with 4.1G, only cells emitting red fluorescence were used to perform the following analyses.
In F12-Dulbecco's modified Eagle's media, A 1 AR-CHO cells were loaded for 20 min with the Ca 2+ -sensitive dye, Fluo-3-AM (where AM stands for acetoxymethyl ester; 25 ng/ml; Molecular Probes, Eugene, OR, U.S.A.), plus Pluronic F127 (50 ng/ml; Molecular Probes) to facilitate Fluo-3-AM entry into the cells. The AM group is cleaved, trapping Fluo-3 inside the cell (Molecular Probes). Coverslips were then mounted on to recording chambers that allowed a laminar-flow exchange of media. Since Fluo-3 is not a ratiometric dye, changes in Fluo-3 intensity reflect changes in relative [Ca 2+ ] i , as described in [18] . A 1 AR-CHO cells were exposed to vehicle or CPA (50 nM) and Fluo-3 intensity was recorded as a function of time. Fluo-3 images were obtained as multi-TIFF files and pixel density within regions of interest covering individual cells were determined. They were expressed as plots of intensity against time (FluoView; Olympus, Melville, NY, U.S.A.).
Data from each cell were normalized by determining the average baseline Fluo-3 intensity value from a minimum of ten time points before addition of CPA and calculating the change in Fluo-3 intensity at each time point sampled as a percentage of the baseline. Normalized plots were averaged across all cells sampled and pooled results were expressed as means + − S.E.M. of Fluo-3 intensity as a function of time. Confocal imaging was performed on at least three separate fields of cells for each coverslip.
Combined A 1 AR immunocytochemistry and plasma-membrane labelling
Immunocytochemistry was performed on A 1 AR-CHO cells with or without co-transfection with 4.1G. Before immunostaining, A 1 AR-CHO cells were incubated with the plasma-membrane marker FM 4-64 (Molecular Probes) at a concentration of 10 µM for 1 h at room temperature 25
• C. A 1 AR-CHO cells were washed with PBS and fixed with 4 % (w/v) PFA for 15 min. After PBS washes, these cells were incubated overnight at 4
• C, with a rabbit anti-A 1 AR antibody (Sigma), diluted 1:50 in 1 % BSA to observe preferential staining of plasma-membrane components. After PBS washes, primary antibody staining was visualized with a fluoroscein-goat anti-rabbit secondary antibody (Vector, Burlingame, CA, U.S.A.), diluted 1:200 in 1 % BSA. After PBS washes, staining patterns for both A 1 AR (green) and FM 4-64 (red) were determined by confocal microscopy.
Computer modelling
BLAST and FASTA searches were first performed to identify if any high homology structures have been determined that map strongly against either the C-terminal (amino acids 773-988) or the helix-loop region of the A 1 AR (amino acids 212-248). We then used the FUGUE approach for alignment and homology detection. To examine potential protein-protein interactions, analysis was conducted with both the A 1 AR (amino acids 212-248) and 4.1G (amino acids 773-988) primary sequences. To arrive at our final prediction, we used the Modeller program developed by Sali and co-workers [19, 20] , with which the primary alignment (PIR format) is used as the basis for a tertiary homology structure model of the interaction. The CHARMM (Chemistry at HARvard Macromolecular Mechanics) potential was used for further refinement and optimization of the homology model [21] .
RESULTS

Identification of 4.1G as an A 1 AR-binding partner
To identify proteins that interact with the cytosolic domain of the rat A 1 AR, a 36-amino-acid region of the third intracellular loop (amino acids 212-248; GenBank ® accession no. AF042079) was used as the 'bait' to screen a rat embryonic cDNA library in the Y2H system. We screened approx. 5 million clones and identified 13 clones that activated the three reporter genes. Further evaluation of these 13 clones involved the re-transformation of yeast with the purified target plasmids and bait. This analysis revealed that four of the original 13 yeast clones expressed proteins that interacted with the third intracellular loop of A 1 AR. These clones contained 650 bp identical inserts. The amino acid sequences of these four clones were the same and identical with the CTD of 4.1G (GenBank ® accession no. AF044312).
Sites of 4.1G CTD-A 1 AR interaction
To determine sites of interaction between A 1 ARs and 4.1G, we examined the interactions between A 1 ARs and truncation mutants of the 4.1G CTD using the Y2H system. Deletion of amino acids 827-988 of 4.1G CTD abolished 4.1G interactions with A 1 ARs (Figure 1 ). Deletion of amino acids 773-945 of 4.1G CTD also eliminated this interaction. Control experiments using a vector expressing only the GAL4 DNA-active domain did not interact with A 1 ARs. We also did not observe interactions between the 4.1G CTD and the C-terminus of A 1 ARs (results not shown). These results suggest that the 4.1G CTD binds to the third intracellular domain of A 1 ARs and is crucial for this interaction. 
Association of A 1 AR with 4.1G in HEK-293 cells
To confirm the association between A 1 ARs and 4.1G, HEK-293 cells were transiently transfected with cDNAs encoding HAtagged 4.1G and His-tagged A 1 AR proteins. Two days after transfection, cells were investigated by immunoprecipitation and double-immunolabelling experiments. Fluorescent microscopic analysis revealed that the two proteins were co-localized both on the plasma membrane and in intracellular compartments (Figure 2) .
Interactions between 4.1G CTD or 4.1G and A 1 ARs were examined using co-immunoprecipitation assays (Figure 3 (Figure 4 , lane 5) were first incubated with anti-HA antibody respectively. Each mixture was then incubated with Protein A/G agarose. After mixtures were centrifuged and washed with PBS, the bound proteins were released by boiling in 2 × SDS loading buffer. Proteins were resolved by SDS/PAGE and then the gels were dried. The dried gels were transferred to a film cassette for development. We observed that the anti-HA antibody specifically co-immunoprecipitated a 4. 
Figure 5 Interaction of 4.1G and A 1 ARs in rat brain tissue
Western-blot analysis was performed on soluble extracts from cerebral cortex using antisera against 4.1G, and two bands of approx. 100 and 120 kDa were seen (lane 1). When antisera against A 1 ARs were used, a band with an apparent molecular mass of 40 kDa was seen (lane 2). Co-immunoprecipitation was performed using antibody directed against 4.1G followed by immunoblotting using antisera against A 1 ARs, and a band of the expected mass of A 1 ARs (lane 3) was observed. This band was not present in immunoprecipitates generated using non-specific IgG (lane 4).
( Figure 4, lane 4) . These results confirm that the 4.1G CTD directly binds to A 1 ARs.
Protein 4.1G interacts with A 1 ARs in brain
Next, we tested for direct 4.1G and A 1 AR interactions in brain by co-immunoprecipitation. When immunoblotting was performed on soluble extracts from the cerebral cortex using antisera against 4.1G, two bands of approx. 100 and 120 kDa were seen ( Figure 5 , lane 1). When antisera against A 1 ARs were used, a band with an apparent molecular mass of 40 kDa was seen ( Figure 5, lane 2) .
Co-immunoprecipitation was performed using antibody directed against 4.1G followed by immunoblotting using antisera against A 1 ARs. We observed a band of the expected mass of A 1 ARs ( Figure 5, lane 3) . This band was not present in immunoprecipitates generated using non-specific IgG ( Figure 5, lane 4) . Thus A 1 ARs and 4.1G appear to interact directly in brain tissue. We also performed immunoprecipitation studies using antisera directed against A 1 ARs followed by immunoblotting using antisera In sham-transfected A 1 AR-CHO cells loaded with Fluo-3-AM, 50 nM CPA (a minimum concentration found to be sufficient to elicit a response) induced transient increases in [Ca 2+ ] i (Figure 7A ). This response is consistent with previous reports regarding changes in [Ca 2+ ] i following A 1 AR activation [24] . However, in A 1 AR-CHO cells transfected with 4.1G, 50 nM CPA failed to trigger increases in [Ca 2+ ] i ( Figure 7B ). Collectively, these results suggest that 4.1G can block A 1 AR-mediated [Ca 2+ ] i release.
4.1G alters the distribution of A 1 ARs
To determine if 4.1G influences A 1 AR expression, we examined cell-surface A 1 AR expression by performing double-labelling studies using A 1 AR antisera and the membrane marker FM 4-64. In sham-transfected A 1 AR-CHO cells, we found that A 1 AR-immunoreactivity (A 1 AR-ir) was distributed both on the peripheral membrane and within the cytoplasm of the cell (Figure 8 ). FM 4-64 labelled both cell surface and intracellular components (Figure 8) , in a manner similar to that observed for A 1 AR-ir. Confirming co-labelling of A 1 AR-ir and FM 4-64 in the same regions of the cell, merged images indicated that many cells had overlapping A 1 AR-ir and FM 4-64.
In A 1 AR-CHO cells that were transfected with the full-length 4.1G, we found that A 1 AR-ir was no longer associated with the cytoplasmic component of the cell and appeared to be present at the periphery of the cell (Figure 8 ). However, when patterns of both A 1 AR-ir and FM 4-64 were examined, overlap was considerably less than that found in A 1 AR-CHO cells not transsfected with 4.1G, indicating that 4.1G alters the distribution of A 1 ARs.
Modelling of 4.1G-A 1 AR interactions
To examine potential 4.1G-A 1 AR physical interactions, computer modelling was performed. Modelling analysis was conducted using the A 1 AR (212-248) and 4.1G (773-988) primary sequences by the FUGUE approach for alignment and homology detection [25] . The A 1 AR sequence was placed at a range of possible positions with respect to the 4.1G sequence. The resulting FUGUE score was used to identify possible candidate tertiary structures for homology modelling.
The best structural candidate was from the structure of a catalytic fragment of the Moloney-murine-leukaemia virus reverse transcriptase [26] . In this candidate structure, the A 1 AR region first forms an α-helix and then a loop region (consistent with the sequence alignment of A 1 AR with bovine rhodopsin; T. Woolf, unpublished work). The 4.1G structure could then be readily extended with more homology modelling to the full structure and its connections to the cytoskeleton. To arrive at our final prediction (Figure 9 ), we used the Modeller program developed by Sali and co-workers [20] , in which the PIR format was used as the basis for a tertiary homology structure model of the interaction. The CHARMM potential was used for further refinement and optimization of the homology model.
A mixture of electrostatic and van der Waals interactions are predicted to underlie the protein-protein recognition for this system. Our candidate structural interaction implicates two interprotein salt bridges and one internal A 1 AR salt bridge as being important for recognition. In addition, a set of possible van [28] . Members of the 4.1 family interact with multiple proteins [29, 30] . The protein 4.1N associates with the metabotrobic glutamate receptor, mGluR1, and co-localizes with (S)-α-amino-3-hydroxy-5,7-methylisoxazole-4-propionic acid receptors at excitatory synapses. Disruption of the interaction of GluR1 with 4.1N or disruption of actin filament results in decreased cell-surface expression of GluR1 [31] . In addition, D 1 , D 2 and D 3 dopamine receptors, which are G protein-coupled receptors, interact with the highly conserved CTD of 4.1R, 4.1G and 4.1B [32] . The binding site of dopamine receptor and 4.1N interaction has been shown to involve the third intracellular domain of D2 and D3 receptors and the CTD of protein 4.1N.
Three main structural/functional domains have been identified in 4.1 proteins [33] . First, a 30 kDa N-terminal membranebinding domain is present that possesses binding sites for integral membrane proteins such as band 3 glycophorin C and CD44 [34] [35] [36] . This domain also binds to p55, calmodulin and phosphatidylserine [37] [38] [39] . Secondly, an internal 10 kDa domain is present that is responsible for the spectrin-actin-binding activity, which plays a critical role in regulating membrane mechanical stability [40, 41] . Thirdly, a 22-24 kDa CTD is present that binds to (i) the immunophilin FKBP13 [42] , (ii) nuclear mitotic apparatus protein NuMA, (iii) tight junction proteins ZO-1 and ZO-2 [39] , (iv) eukaryotic translation initiation factor eIF3-p44 [41] and to (v) ionotropic glutamate receptors (α-amino-3-hydroxy-5,7-methylisoxazole-4-propionic acid and N-methyl-D-aspartate receptors respectively) [43] . It is believed that interactions with 4.1 family members play a role in influencing the localization and clustering of these proteins in the plasma membrane.
In the present study, we observed that the 4.1G expression modified A 1 ] i signalling. In agreement with the results shown here, other studies support the notion that cytoskeletal proteins can influence signaltransduction pathways. The spectrin cytoskeleton anchors signal-transduction molecules, such as protein kinase C to the cell surface, ensuring proper association with target phosphoproteins [44] . Involvement of the spectrin-based cytoskeleton in regulation of signal transduction is also supported by observations of direct interactions of tyrosine kinase binding proteins with the Src homology 3 domain of α-spectrin [45] . Cytoskeletal proteins fodrin and spectrin have been found to inhibit phospholipase A 2 , phospholipase C and phospholipase D by decreasing the membrane content in polyphosphoinositide PIP 2 , the major substrate of phospholipase C, a cofactor for phospholipase D, and an enhancer for cytosolic phospholipase A 2 activity [46] .
Recent studies have shown that the actin cytoskeleton binds to a variety of integral membrane proteins, which e.g. include ion channels, Ca 2+ -Mg 2+ ATPase and N-methyl-D-aspartate receptors [47] [48] [49] [50] . Factors that play a role in anchoring proteins to the cell surface include the ezrin-radixin-moesin proteins that belong to the 4.1 cytoskeletal proteins [51] .
When we examined A 1 AR affinity in HEK-293 cells transfected with A 1 AR and 4.1G, we found that there was altered A 1 ARbinding activity on cell membranes. Since we used [ 3 H]DPCPX, an A 1 AR-selective antagonist, in some of these studies, it is unlikely that the observed effects were secondary to alterations in A 1 AR-G protein coupling. Rather, it is possible that interactions between 4.1G and the third cytoplasmic loop of A 1 ARs modify receptor conformation to alter binding.
In previous studies, expression of the 4.1 family members was detected in the brain. 4.1B (type II brain 4.1), 4.1N (type 1 brain 4.1), 4.1R and 4.1G have been found to be heavily expressed in brain regions including the cerebellum and hippocampus [52] . It is interesting that the white-matter expression of each of these proteins is especially prominent in white-matter tracts and exceeds that seen over grey-matter regions. Similarly, an intriguing feature of A 1 AR expression in the brain is a very high level of A 1 AR expression in white matter, which also exceeds that seen in grey matter [13] . Thus A 1 AR-4.1G interactions may play a role in white-matter A 1 AR expression.
The notion that A 1 ARs can interact with 4.1G and that this interaction can influence A 1 AR actions has significant physiological implications. It has been found that the function and expression of G protein-coupled receptors and their subsequent action can be influenced by cytoskeletal proteins that directly modify the receptor protein in response to receptor occupancy [32] . At present, we do not know whether other types of ARs or other G protein-coupled receptors interact with 4.1G. Since some members of 4.1 family share high homology, it is also quite possible that A 1 ARs interact with other members of the 4.1 family.
Considering that 4.1G can modify A 1 AR action, further studies are indeed indicated to assess if this is a more general feature of 4.1G activity that may broadly influence receptor action.
Overall, we now identify 4.1G as an A 1 AR-binding partner that may play a role in modifying A 1 AR action. Further studies aimed at deciphering the regulation of 4.1G expression may yield new insights into how A 1 AR action and expression are modulated by a cytoskeletal protein.
